Uluwehi O "aminocaproicʻakika": olelo

E hoomakaukau ai "aminocaproicʻakika" - he lāʻau i ua hoʻohana 'ia ma ka hana maikaʻiʻole o ke kahe ana ke koko ma muli i ka mahuahua ma fibrinolytic haʻawina, aplastic, hypoplastic anaemia. Ua Ua hoʻohana 'ia e pale aku haumāna gipofibrinogenemia i nā complications o ka papakaukau transfusion o hoahu i puu koko.

Ka lāʻau 'loaʻa palapala noi i ka kahe ana ke koko fibrinolytic Inc, a i pili iʻoki kino (vascularʻoki kino, naʻau,'ōpū, maʻiʻaʻai).

I ka papa kuhikuhiE ano o: ka pāʻoihana no ka infusion.

E hoomakaukau ai "aminocaproicʻakika". Na Ke Kumu: haku mele 'ana, pharmacokinetics, pharmacodynamics

I ka haku mele 'ana o ka lāʻauʻeleu waiwai - aminocaproicʻakika. Kākoʻo eiiiiiaiou: paʻakai koloriside, maloko wai.

I ka intravenously hookoia ia lŘlŘ loko o iwakālua minuke. Ka lāʻau 'Aʻole i loaʻa i ka hiki ke hoopaa i ka wai koko nā polokina, ka mea, ua excreted ma nā puʻupaʻa i loko o ka kūpono kou unmodified palapala. Ka hapa-ola kīnā kanahiku ehiku minuke. Kēia pākēneka maoli me kaʻoleʻaʻa puʻuwai kuleana pili i. Ka maʻiʻo o ka lāʻau i loko o ke koko i loko o keia hihia maoli ia.

Ka makaukau i ka kekahi hemostatic hookoia, a hōʻoiaʻiʻo laka o ka plasminogen activators, plasmin inhibition hana. Ka lāʻau 'inhibits kinins, biogenic polypeptides ho'ēmi i kā ka permeability o ka liilii, na moku koko. Ua kekahi hōʻike Anati-allergic hana, inhibits ke kahua o ka ho'ākāka 'ia i nā mea'aʻaʻa maoli ka detoxifying ake kuleana pili i.

Ka medicament "aminocaproicʻakika". Instruction: ka papa hana o ka palapala noi, i ka laʻau heluna

Ua makaukau ua manaoia no intravenous hooponopono. Ka mea lāʻau lapaʻau Agena "aminocaproicʻakika" ua ole ia no ka inhalation.

Kela la i keia mahele lāʻau: elima a hiki i ke kanakolu nā huna. Five nā huna lawelawe no ka hora mua, a laila ka mea, hina no kekahi gram (inā pono). Ka lōʻihi like 'ole o ka ka pahu kui mea ewalu hola. No na keiki, i ka laʻau heluna mea e like me ke kaupaona (hoʻokahi haneri milligrams no kilogram).

E hoomakaukau ai "aminocaproicʻakika". Na Ke Kumu:ʻaoʻao waiwai, contraindications

Mawaena o ka mea e hikiʻaoʻao waiwai i i ke kumu ma ka lāʻauʻai ana ua anao? Aou hypotension, bradycardia, arrhythmias, nausea, pōniuniu, ka luaʻi, dyspnea, diarrhea. I loa hoopiiʻaʻa puʻuwai e hemahema, rhabdomyolysis, myoglobinuria, muscular nawaliwali, ua hoʻemi lohe.

Contraindications i ka hoʻohana 'ana i ka lāʻau.

- Hypersensitivity i na eiiiiiaiou;

- hoʻolaha intravascular coagulation ;

- i ka welelau o ka embolism, thrombosis;

- hihia hoʻiʻaʻa puʻuwai hana, cerebral holo;

- hāpai keiki.

E hoomakaukau ai "aminocaproicʻakika". Na Ke Kumu: lāʻau 'hana kūleʻa, kūikawā kauoha, overdose

Ka hoʻohana 'ana i kēia pāʻoihana i hui me ka infusion o isotonic pāʻoihana o ka monakō koko, antishock waiwai hydrolysates. Wā hoʻohana me ka ho'ēmi i kā anticoagulant 'ole coagulation lāʻau.

Ma ke kauoha o ka lāʻau pono e nānā fibrinolytic haʻawina o ke koko wai koko fibrinogen. Mālama nui E e hoʻohana no ka hakuʻala maʻi, naau. I ka kahe ana ke koko, a i IIeEeAIEUIeXAIIUE i loko o ke keena urinary'ōnaehana (no ka mea, o ka mea likelihood kiʻekiʻe o intrarenal iaʻi), ka mea, ua pāpā mai ka hoʻohana 'ana i ka lāʻau "aminocaproicʻakika". Inhalation o ka lāʻau pilikia, no ka mea, ke i hua'ōlelo i makemake systemic loa. Ke k mea i kupono e hoʻohana no ka Kāohiʻana o ka hanau ana o ke kahe ana ke koko, no ka mea, he loa kamepiula o thromboembolic complications.

Symptoms o overdose e like me kēiaʻaoʻao waiwai, nae, ua kaheaia pinepine '. No ka mea Kāohiʻana o kēia kūlana pono a eia i ka mālamaʻana o ka creatine kinase pae.